Using data from SEER databases, Howlader and colleagues recently reported that incidence-based mortality from NSCLC in men decreased from 6.3% annually (95% CI, 3.4 to 9.0) from 2013 through 2016, in contrast to the period between 2006 and 2013, when it decreased by 3.1% annually (95% CI:2.8 to 3.3); In women, incidencebased mortality decreased slowly, by 2.3% annually from 2006 through 2014, and then at…

Trial data can help inform change to standard of care, but at what point do we say enough data is enough and move forward with combination therapy as the new standard of care?

As oncologists, we recognize that the patient–physician relationship is of utmost importance in establishing the patient’s trust in the physician and in the physician’s ability to learn more about the patient’s needs and perform accurate assessments for treatment planning. The majority of this relationship is established through face-to-face office visits. During this time of unprecedented challenge caused by COVID-19, patients are self-quarantining and medical practices are encouraging virtual…

As 7:00 AM approaches, the ninth-floor conference room slowly fills as team members fi le in and find their seats. The senior radiation oncologist identifies his seat in the front row, carefully placing his stack of index cards on the table before him, each identifying a patient’s pertinent history and treatment plan. Soon the room is packed with nurse navigators, clinical research coordinators, residents, fellows, medical…

Coronavirus disease-2019 (COVID-19) is a novel infectious disease, mainly affecting the respiratory tract, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). COVID-19 emerged in Wuhan, China, in December 2019 and rapidly escalated to become a global health crisis. Early reports on the prognosis of patients with cancer with COVID-19 were conflicting and limited.…